Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon

NCT02591225 ·Status: UNKNOWN ·Phase: PHASE4

Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation

NCT02067182 ·Status: COMPLETED ·Phase: PHASE4

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

NCT00448214 ·Status: COMPLETED ·Phase: PHASE2

Sequential Expansion of Comparative Effectiveness of Anticoagulants

NCT02081807 ·Status: COMPLETED

Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

NCT02161731 ·Status: COMPLETED ·Phase: PHASE1

Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

NCT02754154 ·Status: COMPLETED

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.

NCT03715725 ·Status: TERMINATED

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491 ·Status: COMPLETED

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

NCT00781391 ·Status: COMPLETED ·Phase: PHASE3

Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

NCT02546817 ·Status: COMPLETED

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

NCT00291330 ·Status: COMPLETED ·Phase: PHASE3

Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

NCT02450682 ·Status: WITHDRAWN ·Phase: PHASE2

Treatment of Venous Thromboembolism in Real-Life Patients

NCT03087474 ·Status: COMPLETED

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

NCT03189069 ·Status: COMPLETED

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

NCT00558259 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

NCT02164864 ·Status: COMPLETED ·Phase: PHASE3

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

NCT02559232 ·Status: COMPLETED

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

NCT00365950 ·Status: COMPLETED ·Phase: PHASE4

Testing Strategies to Improving Warfarin Adherence

NCT00622102 ·Status: COMPLETED ·Phase: NA

Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF

NCT02256683 ·Status: TERMINATED ·Phase: PHASE2

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

NCT05819112 ·Status: TERMINATED

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

NCT01871194 ·Status: COMPLETED

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

NCT02596230 ·Status: COMPLETED

A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation

NCT03792152 ·Status: UNKNOWN ·Phase: NA

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

NCT02295475 ·Status: COMPLETED ·Phase: PHASE4